Stejskal Pavel MSc

E-mail: pavel.stejskal@upol.cz

Phone: +420 585 632 137

Groups: DOCTORAL STUDENT, IMTM, LEM, MASTER STUDENT, STAFF

Circulating tumor cells detection

Specialization: Molecular and Translational Medicine

Supervisor: Srovnal Josef M.D., Ph.D.

Status: Ongoing from 2020.

Circulating tumor cells detection and analysis using direct detection method in patients with glioblastoma multiforme

Supervisor: Řehulková Alona M.D.

Status: Graduated from 2018 to 2020.

Pavel Stejskal, MSc is involved in the research that aims to understand the additional value of liquid biopsy as a clinically relevant diagnostic, prognostic and predictive tool. His research is focused on the development of experimental models to explain the biology underlying the release of circulating tumor-related materials into blood. He also focuses on the implementation of complex genomic analyses by liquid biopsy-based biomarkers (circulating tumor cells, circulating tumor DNA, extracellular vesicles, free circulating biomarkers) in the diagnosis, follow-up and therapy of cancer patients.

TOLMACI, B., P. STEJSKAL, P. ZUFFA, A. ŘEHULKOVÁ, P. KOUŘILOVÁ, E. BERTA, M. HAJDÚCH, J. KLEIN, J. SROVNAL

Minimal residual disease and prognostic significance of circulating tumour cells in early-stage colorectal cancer. Biomedical papers - Olomouc. 2025, ISSN: 1213-8118, PMID: 40832890, PDF.

MAHESWARAN, S., R. BOREA, D. DE MIGUEL PEREZ, P. PISAPIA, N. GHAZALI, C. MARTINELLI, P. STEJSKAL, C. REDUZZI

Cancer in a Drop: Liquid biopsy insights from AACR 2025. The Journal of Liquid Biopsy. 2025, 8, 100304, ISSN: 2950-1954, PMID: 40613037, PDF.

VIDLAŘOVÁ, M., A. ŘEHULKOVÁ, P. STEJSKAL, A. PROKOPOVÁ, H. SLAVÍK, M. HAJDÚCH, J. SROVNAL

Recent Advances in Methods for Circulating Tumor Cell Detection. International Journal of Molecular Sciences. 2023, 24(4), 3902, ISSN: 1422-0067, PMID: 36835311, PDF.

Stejskal Pavel MSc

Doctoral training

Master training

About me

Journals